{"id":1327,"date":"2026-03-20T12:49:02","date_gmt":"2026-03-20T12:49:02","guid":{"rendered":"https:\/\/event.eortc.org\/ebcc15\/?page_id=1327"},"modified":"2026-03-27T15:00:58","modified_gmt":"2026-03-27T15:00:58","slug":"news","status":"publish","type":"page","link":"https:\/\/event.eortc.org\/ebcc15\/news\/","title":{"rendered":"News"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling back-flower\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-margin-bottom:20px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion-flex-column fusion-flex-align-self-flex-start\" style=\"--awb-padding-top:20px;--awb-padding-right:20px;--awb-padding-bottom:10px;--awb-padding-left:20px;--awb-bg-position:right top;--awb-bg-blend:overlay;--awb-bg-size:60px;--awb-width-large:82%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:82%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"--awb-text-color:var(--awb-color1);--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-font-size:32px;\"><h1 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;font-size:1em;\">15<sup style=\"font-size: 18px;\">TH<\/sup> EUROPEAN BREAST CANCER CONFERENCE<\/h1><\/div><div class=\"fusion-text fusion-text-1 fusion-text-no-margin\" style=\"--awb-font-size:23px;--awb-text-color:var(--awb-color1);--awb-margin-bottom:0px;\"><p><span class=\"light\">25-27 March 2026<\/span>, <span class=\"light\">Barcelona, Spain<\/span><\/p>\n<\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:18%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:18%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-column\"><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion-flex-column\" style=\"--awb-padding-top:10px;--awb-padding-right:20px;--awb-padding-bottom:30px;--awb-padding-left:20px;--awb-bg-color:var(--awb-custom_color_2);--awb-bg-color-hover:var(--awb-custom_color_2);--awb-bg-size:cover;--awb-width-large:82%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:82%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;\"><span class=\"highlight\">Latest<\/span> news<\/h2><\/div><div class=\"fusion-blog-shortcode fusion-blog-shortcode-1 fusion-blog-archive fusion-blog-layout-large fusion-blog-no fusion-blog-no-images\" style=\"--awb-title-font-size:21px;\"><div class=\"fusion-posts-container fusion-posts-container-no\" data-pages=\"0\"><article id=\"blog-1-post-1791\" class=\"fusion-post-large post-1791 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/27\/tumour-dna-circulating-in-patients-blood-after-pre-surgery-treatments-predicts-whether-breast-cancer-will-return\/\">Tumour DNA circulating in patients\u2019 blood after pre-surgery treatments predicts whether breast cancer will return<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Tumour DNA circulating in patients\u2019 blood after pre-surgery treatments predicts whether breast cancer will return <\/p>\n<p><strong>Barcelona, Spain:<\/strong> Fragments of tumour DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/jhardy\/\" rel=\"author\">jhardy<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-27T08:18:01+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/27\/tumour-dna-circulating-in-patients-blood-after-pre-surgery-treatments-predicts-whether-breast-cancer-will-return\/\" aria-label=\"More on Tumour DNA circulating in patients\u2019 blood after pre-surgery treatments predicts whether breast cancer will return\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1784\" class=\"fusion-post-large post-1784 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/27\/early-results-from-a-trial-of-active-surveillance-for-low-risk-dcis-are-reassuring\/\">Early results from a trial of active surveillance for low-risk DCIS are \u2018reassuring\u2019<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Early results from a trial of active surveillance for low-risk DCIS are \u2018reassuring\u2019 <\/p>\n<p>Barcelona, Spain: Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as \u2018reassuring\u2019 in a presentation to the 15th European Breast Cancer Conference (EBCC15) in Barcelona today (Friday).<\/p>\n<p>People diagnosed [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/jhardy\/\" rel=\"author\">jhardy<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-27T08:25:17+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/27\/early-results-from-a-trial-of-active-surveillance-for-low-risk-dcis-are-reassuring\/\" aria-label=\"More on Early results from a trial of active surveillance for low-risk DCIS are \u2018reassuring\u2019\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1797\" class=\"fusion-post-large post-1797 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/26\/radiotherapy-rather-than-surgery-may-help-reduce-risk-of-lymphoedema-in-patients-with-breast-cancer-results-from-pilot-study\/\">Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study <\/p>\n<p>Barcelona, Spain: Patients with breast cancer may be able to avoid lymphoedema, which can occur after surgery to remove lymph nodes in the armpit (the axilla), by having radiotherapy instead.<\/p>\n<p>New findings, [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/jhardy\/\" rel=\"author\">jhardy<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-26T09:30:09+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/26\/radiotherapy-rather-than-surgery-may-help-reduce-risk-of-lymphoedema-in-patients-with-breast-cancer-results-from-pilot-study\/\" aria-label=\"More on Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1782\" class=\"fusion-post-large post-1782 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/26\/hormone-treatment-breast-cancer\/\">Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive <\/p>\n<p>Barcelona, Spain: Results from the OASIS 4 clinical trial last year showed that a new drug, elinzanetant, relieved hot flushes and night sweats that can occur because of the [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/glyn\/\" rel=\"author\">glyn<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-26T09:30:35+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/26\/hormone-treatment-breast-cancer\/\" aria-label=\"More on Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1787\" class=\"fusion-post-large post-1787 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/25\/breast-reconstruction-using-polyurethane-coated-implants-reduces-scarring-and-the-need-for-further-surgery\/\">Breast reconstruction using polyurethane-coated implants reduces scarring and the need for further surgery<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Breast reconstruction using polyurethane-coated implants reduces scarring and the need for further surgery <\/p>\n<p>Barcelona, Spain: Women who are treated with mastectomy for breast cancer often choose to have surgery to reconstruct the breast using an implant. But hard, painful scar tissue can form around the implant, especially when women have [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/jhardy\/\" rel=\"author\">jhardy<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-26T09:34:41+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/25\/breast-reconstruction-using-polyurethane-coated-implants-reduces-scarring-and-the-need-for-further-surgery\/\" aria-label=\"More on Breast reconstruction using polyurethane-coated implants reduces scarring and the need for further surgery\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1854\" class=\"fusion-post-large post-1854 post type-post status-publish format-standard hentry category-uncategorized\">\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/25\/breast-cancer-recurrence-remains-low-even-after-ten-years-with-radiotherapy-tailored-to-patients-individual-risk-2\/\">Breast cancer recurrence remains low, even after ten years, with radiotherapy tailored to patient\u2019s individual risk<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Breast cancer recurrence remains low, even after ten years, with radiotherapy tailored to patient\u2019s individual risk<\/p>\n<p> Barcelona, Spain: The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings of [\u2026]<\/p>\n<\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/event.eortc.org\/ebcc15\/author\/frince\/\" rel=\"author\">frince<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-26T09:27:49+00:00<\/span><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/event.eortc.org\/ebcc15\/2026\/03\/25\/breast-cancer-recurrence-remains-low-even-after-ten-years-with-radiotherapy-tailored-to-patients-individual-risk-2\/\" aria-label=\"More on Breast cancer recurrence remains low, even after ten years, with radiotherapy tailored to patient\u2019s individual risk\">Read More<\/a><\/div><\/div><\/article>\n<\/div><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:18%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:18%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"--awb-flex-grow:0;--awb-flex-grow-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink:0;--awb-flex-shrink-medium:0;--awb-flex-shrink-small:0;width:calc( 100% + 20px ) !important;max-width:calc( 100% + 20px ) !important;margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_1 1_1 fusion-flex-column\" style=\"--awb-padding-right:15px;--awb-padding-bottom:20px;--awb-padding-left:20px;--awb-bg-color:var(--awb-custom_color_2);--awb-bg-color-hover:var(--awb-custom_color_2);--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\">\n<table width=\"100%\">\n<tbody>\n<tr>\n<td align=\"left\">\n<h3 style=\"margin-top: 20px;\">Partners<br \/>\n<span class=\"highlight\">EBCCouncil<\/span><\/h3>\n<\/td>\n<td align=\"right\"><img decoding=\"async\" src=\"\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EBCC-Council-logo.png\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"fusion-image-element\" style=\"text-align:center;--awb-margin-bottom:20px;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><img decoding=\"async\" width=\"170\" height=\"57\" alt=\"EORTC Breast Group - Logo\" title=\"EORTC Breast Group &#8211; Logo\" src=\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EORTC_BCG_828x275_2018.png\" class=\"img-responsive wp-image-303\"\/><\/span><\/div><div class=\"fusion-image-element\" style=\"text-align:center;--awb-margin-bottom:20px;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-2 hover-type-none\"><img decoding=\"async\" width=\"155\" height=\"41\" alt=\"Eusoma - Logo\" title=\"Eusoma &#8211; Logo\" src=\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EUSOMA_LOGO.png\" class=\"img-responsive wp-image-305\" srcset=\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EUSOMA_LOGO-150x41.png 150w, https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EUSOMA_LOGO.png 155w\" sizes=\"(max-width: 155px) 100vw, 155px\" \/><\/span><\/div><div class=\"fusion-image-element\" style=\"text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-3 hover-type-none\"><img decoding=\"async\" width=\"64\" height=\"100\" alt=\"Europa Dona - Logo\" title=\"Europa Dona &#8211; Logo\" src=\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/europa-donna.png\" class=\"img-responsive wp-image-304\"\/><\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1327","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages\/1327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/comments?post=1327"}],"version-history":[{"count":0,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages\/1327\/revisions"}],"wp:attachment":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/media?parent=1327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}